Abstract
It has been a long journey from Pliny the Elder (23–79 AD) to the FDA approval of the first injectable Nanomedicine in 1997. It has been a journey powered by intellectual curiosity, which began with sprinkling olive oil on seawater and culminated in playing around with smears of egg lecithin on microscopic slides. This brief review highlights how a few pairs of gifted hands attached to highly motivated brains have launched Liposome Technology.
Key words
- Liposomes
- Phospholipids
- Biological membranes
- Drug delivery
- Membrane models
This is a preview of subscription content, access via your institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Eichman P (2015) From the Lipid Bilayer to the Fluid Mosaic: A Brief History of Membrane Models. http://www1.umn.edu/ships/9-2/membrane.htm. Accessed 26 May 2015
Tanford C (2004) Ben Franklin stilled the waves. Oxford University Press, Oxford
Langmuir I (1917) The constitution and structural properties of solids and liquids. II. Liquids. J Am Chem Soc 39:1848–1906
Gorter E, Grendel F (1925) On bimolecular layers of lipoids on the chromocytes of the blood. J Exp Med 41:439–443
Danielli JF (1935) The thickness of the wall of the Red blood corpuscle. J Gen Physiol 19:19–22
Singer SJ (1972) A fluid lipid-globular protein mosaic model of membrane structure. Ann N Y Acad Sci 195:16–23
Singer SJ, Nicolson GL (1972) The fluid mosaic model of the structure of cell membranes. Science 175:720–731
Sjostrand FS, Andersson-Cedergren E, Dewey MM (1958) The ultrastructure of the intercalated discs of frog, mouse and guinea pig cardiac muscle. J Ultrastruct Res 1:271–287
Robertson JD (1960) The molecular structure and contact relationships of cell membranes. Prog Biophys Mol Biol 10:343–418
Bangham AD (1989) The first description of liposomes. Curr Content 13:14
Mueller P, Rudin DO, Tien HT, Wescott WC (1962) Reconstitution of cell membrane structure in vitro and its transformation into an excitable system. Nature 194:979–980
Beerlink A, Wilbrandt PJ, Ziegler E, Carbone D, Metzger TH, Salditt T (2008) X-ray structure analysis of free-standing lipid membranes facilitated by micromachined apertures. Langmuir 24:4952–4958
Malmstadt N, Jeon TJ, Schmidt JJ (2007) Long-lived planar lipid bilayer membranes anchored to an in situ polymerized hydrogel. Adv Mater 20:84–89
Deamer DW (2010) From “banghasomes” to liposomes: a memoir of Alec Bangham, 1921–2010. FASEB J 24:1308–1310
Hargreaves WR, Mulvihill SJ, Deamer DW (1977) Synthesis of phospholipids and membranes in prebiotic conditions. Nature 266:78–80
Deamer DW, Pashley RM (1989) Amphiphilic components of the Murchison carbonaceous chondrite: surface properties and membrane formation. Orig Life Evol Biosph 19:21–38
Bangham AD, Horne RW (1964) Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J Mol Biol 8:660–668
Bangham AD, Standish MM, Watkins JC (1965) Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238–252
Bangham AD, Standish MM, Weissmann G (1965) The action of steroids and streptolysin S on the permeability of phospholipid structures to cations. J Mol Biol 13:253–259
Sessa G, Weissmann G (1968) Phospholipid spherules (liposomes) as a model for biological membranes. J Lipid Res 9:310–318
Papahadjopoulos D, Bangham AD (1966) Biophysical properties of phospholipids. II. Permeability of phosphatidylserine liquid crystals to univalent ions. Biochim Biophys Acta 126:185–188
Bangham AD, Papahadjopoulos D (1966) Biophysical properties of phospholipids. I. Interaction of phosphatidylserine monolayers with metal ions. Biochim Biophys Acta 126:181–184
Bangham AD, Standish MM, Watkins JC, Weissmann G (1967) The diffusion of ions from a phospholipid model membrane system. Protoplasma 63:183–187
Bangham AD, Greville GD (1967) Osmotic properties and water permeability of phospholipid crystals. Chem Phys Lipids 1:225–246
Bangham AD, Hill MW, Miller NG (1974) Preparation and use of liposomes as models of biological membranes. In: Korn ED (ed) Methods in membrane biology, vol 1. Plenum Press, New York, pp 1–68
Chan YH, Boxer SG (2007) Model membrane systems and their applications. Curr Opin Chem Biol 11:581–587
Fahr A, Liu X (2010) Utilization of liposomes for studying drug transfer and uptake. Methods Mol Biol 606:1–10
Reed JR (2010) The use of liposomes in the study of drug metabolism: a method to incorporate the enzymes of the cytochrome p450 monooxygenase system into phospholipid, bilayer vesicles. Methods Mol Biol 606:11–20
Kramer R, Nicklisch S, Ott V (2010) Use of liposomes to study cellular osmosensors. Methods Mol Biol 606:21–30
Martinac B, Rohde PR, Battle AR, Petrov E, Pal P, Foo AF, Vasquez V, Huynh T, Kloda A (2010) Studying mechanosensitive ion channels using liposomes. Methods Mol Biol 606:31–53
Indiveri C (2010) Studying amino acid transport using liposomes. Methods Mol Biol 606:55–68
Hofer CT, Herrmann A, Muller P (2010) Use of liposomes for studying interactions of soluble proteins with cellular membranes. Methods Mol Biol 606:69–82
MirAfzali Z, DeWitt DL (2010) Liposomal reconstitution of monotopic integral membrane proteins. Methods Mol Biol 606:83–94
Stamnes M, Xu W (2010) The reconstitution of actin polymerization on liposomes. Methods Mol Biol 606:95–103
Montes LR, Ahyayauch H, Ibarguren M, Sot J, Alonso A, Bagatolli LA, Goni FM (2010) Electroformation of giant unilamellar vesicles from native membranes and organic lipid mixtures for the study of lipid domains under physiological ionic-strength conditions. Methods Mol Biol 606:105–114
Nantes IL, Kawai C, Pessoto FS, Mugnol KC (2010) Study of respiratory cytochromes in liposomes. Methods Mol Biol 606:147–165
Brittes J, Lucio M, Nunes C, Lima JL, Reis S (2010) Effects of resveratrol on membrane biophysical properties: relevance for its pharmacological effects. Chem Phys Lipids 163:747–754
Lucio M, Lima JL, Reis S (2010) Drug-membrane interactions: significance for medicinal chemistry. Curr Med Chem 17:1795–1809
Reis S, Lucio M, Segundo M, Lima JL (2010) Use of liposomes to evaluate the role of membrane interactions on antioxidant activity. Methods Mol Biol 606:167–188
Sabin J, Prieto G, Sarmiento F (2010) Studying colloidal aggregation using liposomes. Methods Mol Biol 606:189–198
Broecker J, Keller S (2010) Membrane translocation assayed by fluorescence spectroscopy. Methods Mol Biol 606:271–289
Fiedler S, Broecker J, Keller S (2010) Protein folding in membranes. Cell Mol Life Sci 67:1779–1798
Takei K, Yamada H, Abe T (2010) Use of liposomes to study vesicular transport. Methods Mol Biol 606:531–542
Raguz M, Mainali L, Widomska J, Subczynski WK (1808) The immiscible cholesterol bilayer domain exists as an integral part of phospholipid bilayer membranes. Biochim Biophys Acta 2011:1072–1080
Subczynski WK, Raguz M, Widomska J (2010) Studying lipid organization in biological membranes using liposomes and EPR spin labeling. Methods Mol Biol 606:247–269
Bangham AD, Hill MW (1986) The proton pump/leak mechanism of unconsciousness. Chem Phys Lipids 40:189–205
Johnson SM, Miller KW, Bangham AD (1973) The opposing effects of pressure and general anaesthetics on the cation permeability of liposomes of varying lipid composition. Biochim Biophys Acta 307:42–57
Miller KW (1983) Anaesthetized Liposomes. Academic, London
Ten Centre Study Group (1987) Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. Br Med J (Clin Res Ed) 294:991–996
Bangham A (2009) The physical chemistry of self/non-self: jigsaws, transplants and fetuses. FASEB J 23:3644–3646
Sessa G, Weissmann G (1970) Incorporation of lysozyme into liposomes. A model for structure-linked latency. J Biol Chem 245:3295–3301
Gruener R, McArdle B, Ryman BE, Weller RO (1968) Contracture of phosphorylase deficient muscle. J Neurol Neurosurg Psychiatry 31:268–283
Leathwood PD, Ryman BE (1970) The use of skin biopsy in the diagnosis of the glycogen-storage diseases. Biochem J 117:34P
Palmer TN, Ryman BE, Whelan WJ (1968) The action pattern of amylomaltase. FEBS Lett 1:1–3
Leserman L (2008) The Gregoriadyssey: from smetic mesophases to liposomal drug carriers, a personal reflection of Gregory Gregoriadis. J Drug Target 16:525–528
Gregoriadis G (1983) How liposomes changed my life and got away with it. In: Bangham AD (ed) Liposome letters. Academic, London, pp 405–407
Gregoriadis G, Ryman BE (1971) Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. Biochem J 124:58P
Gregoriadis G, Leathwood PD, Ryman BE (1971) Enzyme entrapment in liposomes. FEBS Lett 14:95–99
Kirby C, Gregoriadis G (1984) Dehydration-rehydation vesicles: a simple method for high yield drug entrapment in liposomes. Biotechnology 2:979–984
Antimisiaris SG (2010) Preparation of DRV liposomes. In: Weissig V (ed) Liposomes: methods and protocols, vol I. Springer Science+Business Media, Berlin, pp 51–75, Walker JM (Series Editor)
Klibanov AL, Maruyama K, Torchilin VP, Huang L (1990) Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268:235–237
Blume G, Cevc G (1993) Molecular mechanism of the lipid vesicle longevity in vivo. Biochim Biophys Acta 1146:157–168
Needham D, McIntosh TJ, Lasic DD (1992) Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochim Biophys Acta 1108:40–48
Barenholz Y (2012) Doxil(R)--the first FDA-approved nano-drug: lessons learned. J Control Release 160:117–134
Gregoriadis G, Ryman BE (1972) Lysosomal localization of -fructofuranosidase-containing liposomes injected into rats. Biochem J 129:123–133
Allison AG, Gregoriadis G (1974) Liposomes as immunological adjuvants. Nature 252:252
Manesis EK, Cameron CH, Gregoriadis G (1978) Incorporation of hepatitis-B surface antigen (HBsAg) into liposomes. Biochem Soc Trans 6:925–928
Gregoriadis G, Davis D, Davies A (1987) Liposomes as immunological adjuvants: antigen incorporation studies. Vaccine 5:145–151
Gregoriadis G, Panagiotidi C (1989) Immunoadjuvant action of liposomes: comparison with other adjuvants. Immunol Lett 20:237–240
Gregoriadis G, Tan L, Ben-Ahmeida ET, Jennings R (1992) Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen. Vaccine 10:747–753
Gregoriadis G, Wang Z, Barenholz Y, Francis MJ (1993) Liposome-entrapped T-cell peptide provides help for a co-entrapped B-cell peptide to overcome genetic restriction in mice and induce immunological memory. Immunology 80:535–540
Gregoriadis G, Saffie R, de Souza JB (1997) Liposome-mediated DNA vaccination. FEBS Lett 402:107–110
Gregoriadis G, McCormack B, Obrenovich M, Perrie Y (2000) Entrapment of plasmid DNA vaccines into liposomes by dehydration/rehydration. Methods Mol Med 29:305–311
Gregoriadis G (2015) XENETIC Webpage. http://www.xeneticbio.com/about-us. Accessed 26 June 2015
Gregoriadis G (2008) Liposome research in drug delivery: the early days. J Drug Target 16:520–524
Weissig V, Lasch J, Klibanov AL, Torchilin VP (1986) A new hydrophobic anchor for the attachment of proteins to liposomal membranes. FEBS Lett 202:86–90
Kung VT, Redemann CT (1986) Synthesis of carboxyacyl derivatives of phosphatidylethanolamine and use as an efficient method for conjugation of protein to liposomes. Biochim Biophys Acta 862:435–439
Tan L, Weissig V, Gregoriadis G (1991) Comparison of the immune response against polio peptides covalently-surface-linked to and internally-entrapped in liposomes. Asian Pac J Allergy Immunol 9:25–30
Gregoriadis G, Neerunjun ED (1975) Treatment of tumour bearing mice with liponsome-entrapped actinomycin D prolongs their survival. Res Commun Chem Pathol Pharmacol 10:351–362
Gregoriadis G (1976) The carrier potential of liposomes in biology and medicine (second of two parts). N Engl J Med 295:765–770
Gregoriadis G (1976) The carrier potential of liposomes in biology and medicine (first of two parts). N Engl J Med 295:704–710
Gregoriadis G (1978) Liposomes in the therapy of lysosomal storage diseases. Nature 275:695–696
D’Souza GG, Weissig V (2009) Subcellular targeting: a new frontier for drug-loaded pharmaceutical nanocarriers and the concept of the magic bullet. Expert Opin Drug Deliv 6:1135–1148
Gregoriadis G (1977) Targeting of drugs. Nature 265:407–411
Milstein C, Kohler G (1977) Clonal variations of myelomatous cells (proceedings). Minerva Med 68:3453
Kohler G, Pearson T, Milstein C (1977) Fusion of T and B cells. Somatic Cell Genet 3:303–312
Milstein C, Adetugbo K, Cowan NJ, Kohler G, Secher DS, Wilde CD (1977) Somatic cell genetics of antibody-secreting cells: studies of clonal diversification and analysis by cell fusion. Cold Spring Harb Symp Quant Biol 41(Pt 2):793–803
Heath TD, Fraley RT, Papahdjopoulos D (1980) Antibody targeting of liposomes: cell specificity obtained by conjugation of F(ab′)2 to vesicle surface. Science 210:539–541
Leserman LD, Barbet J, Kourilsky F, Weinstein JN (1980) Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A. Nature 288:602–604
Huang A, Huang L, Kennel SJ (1980) Monoclonal antibody covalently coupled with fatty acid A reagent for in vitro liposome targeting. J Biol Chem 255:8015–8018
Torchilin VP, Goldmacher VS, Smirnov VN (1978) Comparative studies on covalent and noncovalent immobilization of protein molecules on the surface of liposomes. Biochem Biophys Res Commun 85:983–990
Torchilin VP, Khaw BA, Smirnov VN, Haber E (1979) Preservation of antimyosin antibody activity after covalent coupling to liposomes. Biochem Biophys Res Commun 89:1114–1119
Weissig V, Pettinger TK, Murdock N (2014) Nanopharmaceuticals (part 1): products on the market. Int J Nanomedicine 9:4357–4373
Weissig V, Guzman-Villanueva D (2015) Nanopharmaceuticals (part 2): products in the pipeline. Int J Nanomedicine 10:1245–1257
Blume G, Cevc G, Crommelin MD, Bakker-Woudenberg IA, Kluft C, Storm G (1993) Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim Biophys Acta 1149:180–184
Gabizon A, Papahadjopoulos D (1988) Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci U S A 85:6949–6953
Allen TM, Chonn A (1987) Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett 223:42–46
Park YS, Maruyama K, Huang L (1992) Some negatively charged phospholipid derivatives prolong the liposome circulation in vivo. Biochim Biophys Acta 1108:257–260
Nandi PK, Legrand A, Nicolau C (1986) Biologically active, recombinant DNA in clathrin-coated vesicles isolated from rat livers after in vivo injection of liposome-encapsulated DNA. J Biol Chem 261:16722–16726
Nicolau C (1984) Liposomes for gene transfer and expression in vivo. Biochem Soc Trans 12:349–350
Nicolau C, Cudd A (1989) Liposomes as carriers of DNA. Crit Rev Ther Drug Carrier Syst 6:239–271
Nicolau C, Le Pape A, Soriano P, Fargette F, Juhel MF (1983) In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I. Proc Natl Acad Sci U S A 80:1068–1072
Nicolau C, Legrand A, Grosse E (1987) Liposomes as carriers for in vivo gene transfer and expression. Methods Enzymol 149:157–176
Nicolau C, Legrand A, Soriano P (1984) Liposomes for gene transfer and expression in vivo. Ciba Found Symp 103:254–267
Nicolau C, Rottem S (1982) Expression of a beta-lactamase activity in Mycoplasma capricolum transfected with the liposome-encapsulated E.coli pBR 322 plasmid. Biochem Biophys Res Commun 108:982–986
Nicolau C, Sene C (1982) Liposome-mediated DNA transfer in eukaryotic cells. Dependence of the transfer efficiency upon the type of liposomes used and the host cell cycle stage. Biochim Biophys Acta 721:185–190
Soriano P, Dijkstra J, Legrand A, Spanjer H, Londos-Gagliardi D, Roerdink F, Scherphof G, Nicolau C (1983) Targeted and nontargeted liposomes for in vivo transfer to rat liver cells of a plasmid containing the preproinsulin I gene. Proc Natl Acad Sci U S A 80:7128–7131
Wong TK, Nicolau C, Hofschneider PH (1980) Appearance of beta-lactamase activity in animal cells upon liposome-mediated gene transfer. Gene 10:87–94
Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M (1987) Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 84:7413–7417
Elbayoumi TA, Torchilin VP (2010) Current trends in liposome research. Methods Mol Biol 605:1–27
Weissig V (2010) Liposomes—methods and protocols. Preface. Methods Mol Biol v–vi
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Weissig, V. (2017). Liposomes Came First: The Early History of Liposomology. In: D'Souza, G. (eds) Liposomes. Methods in Molecular Biology, vol 1522. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6591-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6591-5_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6589-2
Online ISBN: 978-1-4939-6591-5
eBook Packages: Springer Protocols